HealthDay on MSN1h
Drug Can Stave Off Organ Damage From LupusLupus can do irreversible harm to a person’s organs, damaging the lungs, kidneys, heart, liver and other vital orga ...
Adding the anti-CD20 monoclonal antibody obinutuzumab (Gazyva) to standard therapy for lupus nephritis is more efficacious ...
The FDA has accepted an investigational new drug application for ALLO-329, an allogeneic chimeric antigen receptor T-cell ...
The Lupus Foundation of America is a nonprofit whose mission is to "improve the quality of life for all people affected by ...
Biogen has bagged $250 million to advance a key pipeline prospect. | Biogen has bagged $250 million to advance a key pipeline ...
People with lupus are at an increased risk of depression. Lupus is a chronic condition with recurring symptoms that can ...
Obinutuzumab B-cell depleting therapy is more effective than standard care in treating patients with active proliferative lupus nephritis.
EXCLUSIVE: Loose Women star Kelly Bryan opened up about her ongoing battle with lupus - a condition she has been living with ...
Roche’s Gazyva/Gazyvaro (obinutuzumab) has demonstrated superiority over standard therapy in patients with active lupus ...
While Roche’s Gazyva has been on the market for a dozen years and has won four approvals from the FDA, it is making a late ...
Recent decades have witnessed remarkable strides in the realm of clinical research and treatment for Systemic Lupus Erythematosus (SLE) and Sjögren’s ...
The FDA has granted Fast Track Designation to Adicet Bio’s ADI-001, an allogeneic gamma delta CAR T-cell therapy, for ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback